Morning Light Dose as a Buffer Against Evening Screen-Induced Sleep Latency Variability

Hypothesis

Morning light dose determines how much evening screen exposure perturbs sleep latency variability. We're proposing that a minimum melanopsin‑activating dose of morning light (≈1000 lux·min before 10 a.m.) raises circadian amplitude enough to blunt the phase‑delaying effect of evening blue‑light, thereby reducing the night‑to‑night SD of sleep latency.

Mechanism

Melanopsin activation in the SCN drives PER2 transcription, increasing the amplitude of the core circadian loop. A higher amplitude raises the threshold for light‑induced phase shifts because the opposing PER/CRY feedback is stronger (source). Morning light also desensitizes the SCN to subsequent evening photons, a form of homeostatic plasticity shown to reduce sensitivity to evening light’s delaying power (source). When this threshold is met, evening screen light produces smaller melatonin suppression and a smaller delay of the sleep onset process, which translates into lower variability in sleep latency across nights.

Prediction

If the hypothesis is correct, individuals who receive at least 1000 lux·min of morning light will show a significantly smaller increase in sleep‑latency SD after a standardized evening screen challenge (e.g., 2 h of 480 nm light at 100 lux) compared with those who receive less morning light. We don't expect a flat relationship; each additional 30 min of morning sunlight before 10 a.m. should reduce the evening‑screen‑induced SD increase by about 15 % (source).

Test

1. Recruit 60 adults with varying habitual light patterns.
2. Equip each with a wearable photodiode that logs lux and wavelength binned into the 460‑480 nm band, yielding a daily morning melanopsin dose.
3. Use contactless radar‑based sleep monitoring to compute nightly sleep latency and its SD over a two‑week baseline (source).
4. On two counterbalanced evenings, expose participants to either bright screen light (480 nm, 100 lux, 2 h) or dim control light (<10 lux) while keeping other conditions constant.
5. Measure the change in sleep‑latency SD from baseline to the exposure night.
6. Model the change as a function of morning melanopsin dose using mixed‑effects regression; a significant negative slope supports the hypothesis.

Falsifiability

If morning light dose doesn't predict the magnitude of evening‑screen‑induced SD change, or if the slope is positive (more morning light worsens variability), the hypothesis is falsified. Similarly, if actigraphy‑derived latency shows no SD modulation despite clear melatonin suppression, the proposed mechanistic link between circadian amplitude and latency variability would need revision.

Keywords

melanopsin, sleep latency variability, circadian amplitude, light dosing, contactless monitoring